Work

Supplementary Table S2 from Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma

Year: 2024

Type: supplementary-materials

DOI: 10.1158/1078-0432.26711163

Authors: Jennifer Jess, Katie M. Sorensen, Elissa A. Boguslawski, Matthew C. Stout, Zachary B. Madaj, Benjamin P. Caiello, Monica Pomaville, Elizabeth R. Wilson, Seneca S. Kinn-Gurzo, Curtis C. Parker, Sridhar M. Veluvolu, Taylor V. Brysgel, Rebecca Kaufman, Susan M. Kitchen-Goosen, Jenna M. Gedminas, Patrick J. Grohar

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4401619332

Cites:

Cited by:

Related to: 10